Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.52 and traded as low as $0.80. Eagle Pharmaceuticals shares last traded at $1.30, with a volume of 565 shares.
Eagle Pharmaceuticals Trading Down 13.3%
The stock’s 50 day moving average is $2.10 and its two-hundred day moving average is $2.52. The stock has a market cap of $16.88 million, a price-to-earnings ratio of 1.10 and a beta of 0.83.
About Eagle Pharmaceuticals
Eagle Pharmaceuticals, Inc, a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma.
Featured Stories
- Five stocks we like better than Eagle Pharmaceuticals
- How to Calculate Return on Investment (ROI)
- Tesla Has Been Trapped in a 10% Range for Months—What’s Going On?
- How to invest in marijuana stocks in 7 steps
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- Which Wall Street Analysts are the Most Accurate?
- Ondas Holdings Signals a Rebound as Drone Demand Soars
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
